However, the treatment of NIU is very similar to that of other immune-mediated pathologies such as RA or IBD, where the influence of genetic polymorphisms on the response to biological drugs such as anti-TNFα has been evaluated [128]. The gene discussed is TNF; the disease is inflammatory bowel disease.